Fractyl Health, Inc (GUTS): Company Cash Volume

Fractyl Health - graphic logo of issuer GUTS

Fractyl Health, Inc. (GUTS) is expanding within an autonomous hydrogel therapy implementation cycle, rendering the business crisis-resistant. The GURU.Markets interface displays this chart, where the company's cash history demonstrates that the indicator value reaches 0.03. Liquidity supports a team of top endocrinologists motivated by stock options, as well as the success of the Revita system and anticipated FDA approvals.

Company Cash Balance: Fractyl Health Inc. (GUTS) for 02/21/2024 - 11/21/2026

Metric breakdowns and analytics for Fractyl (GUTS)

- stock value and consensus price forecast:
- stock exchange capitalization data:
Summary company analysis:Fractyl Health Inc. GUTS
Brand item of Fractyl Health Inc.

An investment audit of the issuer requires an assessment of its ability to cover operating expenses without debt obligations. This metric aggregates cash and highly liquid equivalents to determine the business's financial autonomy. For Fractyl Health (GUTS), whose management transparently discloses clinical trial data, the cash runway trend confirms the resource base necessary for developing innovative therapies.